•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A05840 Summary:

BILL NOA05840
 
SAME ASNo Same As
 
SPONSORSteck
 
COSPNSR
 
MLTSPNSR
 
Amd §2803-u, Pub Health L; amd §29.15, Ment Hyg L
 
Requires inpatient facilities to dispense at-risk individuals with opioid reversal drugs upon discharge.
Go to top

A05840 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A5840    REVISED 2/26/25
 
SPONSOR: Steck
  TITLE OF BILL: An act to amend the public health law and the mental hygiene law, in relation to dispensing certain individuals with opioid reversal drugs upon discharge   SUMMARY OF PROVISIONS: (b) Upon discharge of an individual who appears to be at risk for a substance use disorder, such hospital shall dispense at least two doses of opioid reversal drugs. (o)Upon discharge from an inpatient facility operated or licensed by the office of alcoholism and substance abuse services or the office of mental health, a patient who appears to be at risk for a substance use disorder shall be dispensed at least two doses of opioid reversal drugs.   PURPOSE AND JUSTIFICATION: Under current law, hospitals or substance use treatment facilities are recommended to inform an individual upon discharge of the availability of opioid reversal drugs and have the option to prescribe them to a patient. This legislation would simply require a hospital or substance use treat- ment facility to prescribe or dispense at least two doses of opioid reversal drugs to a patient upon discharge. By enacting this legis- lation, New York State will increase access to lifesaving opioid reversal drugs to those who are at risk for substance use disorder.   EXISTING LAW: None.   PRIOR LEGISLATIVE HISTORY: New legislation.   FISCAL IMPLICATIONS: To be determined.   EFFECTIVE DATE: This act shall take effect immediately.
Go to top